A serial biotech entrepreneur launches his next startup with high-dollar backing
BioPharma
Stay updated with breaking news from Gary Glick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Odyssey Therapeutics is the latest startup formed by serial biotech entrepreneur Gary Glick. Odyssey’s destination is oncology and immunology drugs that address novel disease targets, and the biotech now has $218 million in Series A financing to fuel the journey.
Do you know what this mystery tool, from the collection of the Landis Valley Village and Farm Museum, was used for?
Do you know what this mystery tool, from the collection of the Landis Valley Village and Farm Museum, was used for?
Last week I called my old friend Frank Faucett to wish him a happy 93 rd birthday. He was not only a member of the 1949 Raisin Bowl team, but also played ha...